Jorgensen Nathan D.
SEC insider (Form 3/4/5 filer). CIK 0001842523. Chief Financial Officer at Voyager Therapeutics, Inc. (VYGR). 5 reported Form 4/5 transactions since Sep 2024; latest on Feb 24, 2026. Located in LEXINGTON, MA.
Companies Jorgensen Nathan D. has filed insider reports for
- Voyager Therapeutics, Inc. (VYGR): Officer, Chief Financial Officer
Jorgensen Nathan D.
CIK: 0001842523
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (40.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (60.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VYGR
Voyager Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Feb 24, 2026VYGR
Voyager Therapeutics, Inc.
SaleDirect4.7K shares at avg. $3.77$18K - Feb 6, 2026VYGR
Voyager Therapeutics, Inc.
AwardDirect32.3K shares- - Oct 3, 2025VYGR
Voyager Therapeutics, Inc.
SaleDirect7.7K shares at avg. $4.78$37K - Feb 21, 2025VYGR
Voyager Therapeutics, Inc.
AwardDirect51.5K shares- - Oct 1, 2024VYGR
Voyager Therapeutics, Inc.
AwardDirect80K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 24, 2026 | VYGR Voyager Therapeutics, Inc. | Sale | 4,668 | $3.77 | $17,598 | Direct |
| Feb 6, 2026 | VYGR Voyager Therapeutics, Inc. | Award | 32,250 | - | $0 | Direct |
| Oct 3, 2025 | VYGR Voyager Therapeutics, Inc. | Sale | 7,666 | $4.78 | $36,643 | Direct |
| Feb 21, 2025 | VYGR Voyager Therapeutics, Inc. | Award | 51,500 | - | - | Direct |
| Oct 1, 2024 | VYGR Voyager Therapeutics, Inc. | Award | 80,000 | - | $0 | Direct |
1-5 of 5 transactions